6096
J. Am. Chem. Soc. 1996, 118, 6096-6097
Scheme 1
Synthesis of the Polycyclopropane Antibiotic
FR-900848 via the Horeau Gambit
J. R. Falck,* Belew Mekonnen, Jurong Yu, and Jing-Yu Lai
Departments of Molecular Genetics and Pharmacology
UniVersity of Texas Southwestern Medical Center
Dallas, Texas 75235
ReceiVed April 3, 1996
StreptoVerticillium ferVens elaborates a unique nucleoside
antibiotic, FR-900848 (1), whose structure was published
without assignment of relative or absolute configurations.1 It
displays potent and highly specific inhibitory activity against
filamentous fungi including several pathogens responsible for
significant human morbidity/mortality but is almost inactive
against Gram-positive and Gram-negative bacteria. In light of
its low toxicity in mammals (murine LD50 > 1g/kg), 1 represents
a promising new lead to counter the alarming increase in the
incidence of systemic fungal infections as well as the concomi-
tant appearance of drug resistant strains.2 The most distinctive
structural feature of 1 is its lipidic proboscis endowed with five
cyclopropane rings. Such unprecedented functionality poses a
daunting synthetic challenge and accordingly has engendered
considerable attention3 that has culminated in a recent total
synthesis.4 Herein, we describe a conceptually distinct approach
to 1 that (a) independently confirms the complete architecture
of FR-900848, (b) validates methodology for the stereocon-
trolled assembly of polycyclopropanes,5 and (c) illustrates a
variant of the Horeau principle6 leading to material of high
enantiomeric enrichment.
A retrosynthetic analysis, outlined in Scheme 1, bisected 1
into fatty acid 2 and dihydrouridine 3. The former was
provisionally assigned an all-trans stereochemistry based on
biogenetic considerations7 and the latter was presumed to have
the configuration typical of nucleosides. Moiety 2 was simpli-
fied further by dismantling into monocyclopropane 4, tetracy-
clopropane 5, and the Horner-Emmons reagent 6.8 Additional
insight into the configuration of 1 came from its ozonolytic
degradation by Fujisawa scientists.9 The 13C NMR spectrum
of the serial tetracyclopropane fragment revealed seven reso-
nances only and was most consistent with a meso or C2-
symmetric product. Combined with extensive NMR compari-
sons with the syn/anti-bicyclopropanes generated from 2,4-
hexadiene-1,6-diol (mucondiol) via nonselective cyclopropanation,
an all-trans, all-syn geometry for 2 was targeted. The absolute
configuration was selected arbitrarily and would be confirmed
en route by comparison with a suitable degradation fragment
from natural material.
A reiterative dimerization strategy10,11 (Scheme 2) was
embraced for the preparation of the tetracyclopropane core of
2 and commenced with a moderately stereospecific (88-90%
ee) Charette-Juteau12 asymmetric cyclopropanation of trans-
allylic alcohol 7.13 Silylation of the derived cyclopropylmetha-
nol14 under standard conditions furnished stannane 8 which was
transmetalated with sec-BuLi. The newly generated lithium
15
anion was added to [ICuPBu3]4 and then subjected to an O2-
induced16 dimerization17 at low temperature to give syn-
trans,trans-bicyclopropane 9 (98% ee18), [R]D23 -41.5° (c 0.23,
absolute EtOH). The enrichment in enantiomeric composition
is a manifestation of the statistical distribution of products and
represents a variant of the Horeau amplification principle.6
Classical resolution techniques are obviated and greater latitude
regarding optical purity of precursors is possible.
(1) Yoshida, M.; Ezaki, M.; Hashimoto, M.; Yamashita, M.; Shigematsu,
N.; Okuhara, M.; Kohsaka, M.; Horikoshi, K. J. Antibiotics 1990, 43, 748-
754.
(2) Sternberg, S. Science 1994, 266, 1632-1634. Georgopapadakou, N.
H.; Walsh, T. J. Ibid. 1994, 264, 371-373.
As a prelude to the next level of dimerization (and its
attendant Horeau amplification), 9 was converted to carboxylic
acid 10 via selective fluoride cleavage of one silyl ether and
RuCl3-catalyzed oxidation of the liberated alcohol. The one-
(3) Theberge, C. R.; Zercher, C. K. Tetrahedron Lett. 1994, 35, 9181-
9184. Armstrong, R. W.; Maurer, K. W. Ibid. 1995, 36, 357-360. Barrett,
A. G. M.; Kasdorf, K.; Williams, D. J. J. Chem. Soc., Chem. Commun.
1994, 1781-1782. Barrett, A. G. M.; Doubleday, W. W.; Tustin, G. J.;
White, A. J. P.; Williams, D. J. Ibid. 1994, 1783-1784. Barrett, A. G. M.;
Tustin, G. J. Ibid. 1995, 355-356. Barrett, A. G. M.; Doubleday, W. W.;
Kasdorf, K.; Tustin, G. J.; White, A.J. P.; Williams, D. J. Ibid. 1995, 407-
408. Barrett, A. G. M.; Kasdorf, K.; White, A. J. P.; Williams, D. J. Ibid.
1995, 649-650. Barrett, A. G. M.; Kasdorf, K.; Tustin, G. J.; Williams, D.
J. Ibid. 1995, 1143-1144.
(4) Barrett, A. G. M.; Kasdorf, K. Chem. Commun. 1996, 325-326.
(5) Examples of polycyclopropane syntheses: Conia, J. M.; Denis, J.
M. Tetrahedron Lett. 1969, 3545-3546. Ripoll, J. L.; Limasset, J. C.; Conia,
J. M. Tetrahedron 1971, 27, 2431-2452. Kostikov, R. R.; Molchanov, A.
P. Zh. Org. Khim. 1978, 14, 1108-1109. de Meijere, A.; Jaekel, F.; Simon,
A.; Borrmann, H.; Kohler, J.; Johnels, D.; Scott, L. T. J. Am. Chem. Soc.
1991, 113, 3935-3941.
(6) For a thorough discussion of the Horeau amplification principle,
see: Rautenstrauch, V. Bull. Soc. Chim. Fr. 1994, 131, 515-524.
(7) We speculate that the odd-numbered C23-acid 2 is derived biogene-
ticially from an even-numbered C18-polyunsaturated fatty acid and that the
cyclopropanes arise from the addition of one-carbon units donated by
S-adenosylmethionine or its equivalent. Since the thermodynamically most
stable form of this hypothetical precursor is all-trans, then the cyclopropanes
and olefins in 2 would also be trans.
(9) Dr. Hirokazu Tanaka (Fujisawa Pharmaceutical Co., Ltd.), personal
communication.
(10) Dimerizations of cyclopropane anions have precedence: Slabey, V.
A. J. Am. Chem. Soc. 1952, 74, 4928-4930. Kai, Y.; Knochel, P.;
Kwiatkowski, S.; Dunitz, J. D.; Oth, J. F. M.; Seebach, D. HelV. Chim.
Acta 1982, 65, 137-161. O'Bannon, P. E.; Dailey, W. P. J. Am. Chem.
Soc. 1989, 111, 9244-9245.
(11) The geometric progression (2n units/dimerization) inherent in this
strategy allows one to rapidly accrue repeating functionality. This would
be especially important for the preparation of higher homologs of 1
containing, for example, eight serial cyclopropanes.
(12) Review: Charette, A. B.; Marcoux, J.-F. Synlett 1995, 1197-1207.
(13) Imai, N.; Sakamoto, K.; Takahashi, H.; Kobayashi, S. Tetrahedron
Lett. 1994, 35, 7045-7048. Jung, M. E.; Light, L. A. Ibid. 1982, 23, 3851-
3854.
(14) All isolated intermediates were fully characterized by 1H/13C NMR
and MS analysis. The elemental composition of an analytical sample was
confirmed by combustion analysis or high-resolution mass spectroscopy.
(15) Whitesides, G. M.; Casey, C. P.; Krieger, J. K. J. Am. Chem. Soc.
1971, 93, 1379-1389.
(16) Lipshutz, B. H.; Kayser, F.; Maullin, N. Tetrahedron Lett. 1994,
35, 815-818.
(17) cf.: Walborsky, H. M.; Banks, R. B.; Banks, M. L. A.; Duraisamy,
M. Organometallics 1982, 1, 667-674.
(18) Chiral phase HPLC analysis was performed on a Chiralcel OD
column (Daicel, 4.6 × 250 mm) using 0.8% i-PrOH/hexane at a flow rate
of 1 mL/min. The bis-(S)-Mosher ester of 9 had a Rt ≈ 16.7 min and the
bis-(S)-Mosher ester of its enantiomer had a Rt ≈ 29 min.
(8) Available from Aldrich Chem. Co.
S0002-7863(96)01093-1 CCC: $12.00 © 1996 American Chemical Society